3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pancreatic Neoplasms
11
Neoplasms
5
Stomach Neoplasms
2
Small Cell Lung Carcinoma
2
Ovarian Neoplasms
2
Metastatic Pancreatic Adenocarcinoma
2
Head and Neck Neoplasms
2
Glioma
2
Colorectal Neoplasms
2
Biliary Tract Neoplasms
2
Weight Loss
1
Triple Negative Breast Neoplasms
1
Solid Tumor
1
Refractory Solid Tumors
1
Pseudomyxoma Peritonei
1
Pancreatic cancer, adult
1
Pancreatic Diseases
1
Oligodendroglioma
1
Neoplasms, Cystic, Mucinous, and Serous
1
Metastatic Adenocarcinoma of the Pancreas
1
Mesothelioma
1
Malignant Solid Neoplasm
1
Locally Advanced Rectal Cancer (LARC)
1
Locally Advanced Pancreatic Carcinoma(LAPC)
1
Gliosarcoma
1
Glioblastoma
1
Fallopian Tube Neoplasms
1
Endocrine Gland Neoplasms
1
Disease
1
Digestive System Neoplasms
1
Interventions
Exercise
6
Diet
6
Octreotide
3
Metformin
3
Caloric Restriction
3
Diet, Carbohydrate-Restricted
2
Cognitive Behavioral Therapy
2
sibutramine
1
remune
1
olanzapine-fluoxetine combination
1
irinotecan sucrosofate
1
bermekimab
1
Weight Reduction Programs
1
TOPS
1
Surveys and Questionnaires
1
Sugars
1
Standard of Care
1
Sampling Studies
1
Ritonavir
1
Resistance Training
1
Quality of Life
1
Psychology, Positive
1
Palonosetron
1
Palliative Care
1
Olanzapine
1
Nutritionists
1
Nutritional Status
1
Nutrition Assessment
1
Methods
1
Melatonin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Weight Loss
×
irinotecan sucrosofate
×
Clear all
NCT03207724
2020-12-30
OnFX
Cedars-Sinai Medical Center
Phase 1
Completed
16 enrolled